Clinical Trials: What to Expect in 2025 - a Preview of Trials Planned to Initiate and Estimated to Complete
Summary
This report provides a preview of clinical trials that are planned to be initiated and projected to be completed in 2025.
Identify key analysis and segmentation of these trials by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, drug type, and DCT use.
Scope
- This report provides an overview of clinical trials that are planned to be initiated and projected to be completed in 2025 captured in the GlobalData Pharma Intelligence Center until December 19, 2024. In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.
- See a preview of the clinical trials that are planned to be initiated and those projected to be completed in 2025.
- Identify key analysis and segmentation of these trials by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, drug type, and DCT use.
- 1. Tables and Figures
- 2. Executive Summary
- 3. Introduction
- 4. Clinical Trials Planned to Initiate 2025
- 5. Clinical Trials Estimated to Complete in 2025
- 6. Key Findings
- 7. Appendix
- List of Tables
- Table 1: Construction Industry Key Data
- Table 2: Spain, Key Economic Indicators
- Table 3: Spain, Commercial Construction Output by Project Type (Real % Change), 2019-28
- Table 4: Spain, Top Commercial Construction Projects by Value
- Table 5: Spain, Industrial Construction Output by Project Type (Real % Change), 2019-28
- Table 6: Spain, Top Industrial Construction Projects by Value
- Table 7: Spain, Infrastructure Construction Output by Project Type (Real % Change), 2019-28
- Table 8: Spain, Top Infrastructure Construction Projects by Value
- Table 9: Spain, Energy and Utilities Construction Output by Project Type (Real % Change), 2019-28
- Table 10: Spain, Top Energy and Utilities Construction Projects by Value
- Table 11: Spain, Institutional Construction Output by Project Type (Real % Change), 2019-28
- Table 12: Spain, Top Institutional Construction Projects by Value
- Table 13: Spain, Residential Construction Output by Project Type (Real % Change), 2019-28
- Table 14: Spain, Top Residential Construction Projects by Value
- Table 15: Spain, Key Contractors
- Table 16: Spain, Key Consultants
- Table 17: Spain, Construction Output Value (Real, $ Million)
- Table 18: Spain, Construction Output Value (Nominal, EUR Million)
- Table 19: GlobalData Construction Market Definitions
- Table 20: Risk Dimensions
- Table 21: Ratings, Scores and Definitions
- List of Figures
- Figures 1 and 2: Planned clinical trials, by phase and sponsor type
- Figure 3: Planned clinical trials, top industry sponsors, by phase
- Figure 4: Planned clinical trials, top non-industry sponsors, by phase
- Figure 5: Planned clinical trials, single-country or multinational, by sponsor type and phase
- Figure 6: Planned clinical trials, regions, by phase
- Figure 7: Planned clinical trials, regions, by phase and distribution
- Figure 8: Planned clinical trials, country, by phase
- Figure 9: Planned clinical trials, country, by phase and distribution
- Figures 10 and 11: Planned clinical trials, drug type, by phase and distribution
- Figure 12: Planned clinical trials, top therapy areas, by phase
- Figure 13: Planned clinical trials, top therapy areas, by phase and distribution
- Figure 14: Planned clinical trials, top indications, by phase
- Figure 15: Planned clinical trials, top indications, by phase and distribution
- Figures 16 and 17: Total planned DCTs, by therapeutic area
- Figure 18: Clinical trials estimated to complete, by phase
- Figures 19 and 20: Clinical trials estimated to complete, by status and phase distribution
- Figure 21: Clinical trials estimated to complete, by sponsor type and phase
- Figure 22: Clinical trials estimated to complete, by top industry sponsor and phase
- Figure 23: Clinical trials estimated to complete, by top non-industry sponsor and phase
- Figure 24: Single-country or multinational clinical trials estimated to complete, by region
- Figure 25: Clinical trials estimated to complete, by country
- Figure 26: Clinical trials estimated to complete, by therapy area and phase
- Figures 27 and 28: Total DCTs estimated to complete, by region and single-country or multinational
- Figure 29: DCTs estimated to complete, by therapy area and phase
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook